N-Acetylneuraminic acid
0N-Acetylneuraminic acid (also known as Neu5Ac) is a derivative of the monosaccharide neuraminic acid. It is a significant component of glycoconjugates, such as glycoproteins and glycolipids, which contribute to cellular functions like cell-cell interaction, molecular recognition, and immune response.
Structure and Properties
N-Acetylneuraminic acid is a nine-carbon monosaccharide. It is composed of a pyranose ring with an acetyl group attached to the fifth carbon and a carboxyl group at the second carbon. The molecule also contains a hydroxyl group at the third and fourth carbons and a N-acetyl group at the fifth carbon.
Biological Role
N-Acetylneuraminic acid plays a crucial role in biological systems. It is a major component of the glycocalyx, a glycoprotein and glycolipid covering that surrounds the cell membranes of some cells. It is also involved in various biological processes such as cell-cell adhesion, immune response, and pathogen recognition.
In humans, N-Acetylneuraminic acid is the predominant sialic acid found in the brain, milk, and other tissues. It is also a key component of gangliosides, which are complex glycosphingolipids present in the plasma membrane of nerve cells.
Synthesis and Metabolism
N-Acetylneuraminic acid is synthesized from glucose and glutamine in a pathway that involves several enzymes, including UDP-N-acetylglucosamine 2-epimerase and sialic acid synthase. It can be metabolized by sialidase enzymes, which cleave the glycosidic linkages of sialic acids.
Clinical Significance
Alterations in the metabolism of N-Acetylneuraminic acid have been associated with various diseases, including cancer, influenza, and neurodegenerative diseases. For instance, many cancer cells have an increased expression of sialic acids on their surface, which can contribute to their ability to evade the immune system.
This article is a biochemistry stub. You can help WikiMD by expanding it!
This article is a Cell biology-related stub. You can help WikiMD by expanding it!
```
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD